Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor γ is mediated by up-regulation of B7H1

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 129-136

  Klotz, Luisa ^a,b   Hucke, Stephanie ^a   Thimm, Dominik ^a   Classen, Sabine ^b   Gaarz, Andrea ^b   Schultze, Joachim ^b   Edenhofer, Frank ^c   Kurts, Christian ^a   Klockgether, Thomas ^b   Limmer, Andreas ^a   Knolle, Percy ^a   Burgdorf, Sven ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Life and Brain Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE RECEPTOR; OVALBUMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGRAMMED DEATH 1 LIGAND 1; B7 ANTIGEN; CELL SURFACE RECEPTOR; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; MANNOSE BINDING LECTIN; MEMBRANE PROTEIN; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; ENDOCYTOSIS; EXON; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COCULTURE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CROSS-PRIMING; DENDRITIC CELLS; IMMUNE TOLERANCE; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; PEPTIDES; PPAR GAMMA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 68949143163     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804260     Document Type: Article

References (43)

1. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
2. Trombetta, E. S., M. Ebersold, W. Garrett, M. Pypaert, and I. Mellman. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299: 1400-1403.
3. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
4. Kurts, C., W. R. Heath, F. R. Carbone, J. Allison, J. F. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184: 923-930. (Pubitemid 26313550)
5. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89.
6. + T cell tolerance to peripherally expressed antigens. J. Immunol. 163: 723-727.
7. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961-965. (Pubitemid 24196166)
8. Burgdorf, S., A. Kautz, V. Bohnert, P. A. Knolle, and C. Kurts. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316: 612-616.
9. Burgdorf, S., and C. Kurts. 2008. Endocytosis mechanisms and the cell biology of antigen presentation. Curr. Opin. Immunol. 20: 89-95.
10. Burgdorf, S., V. Lukacs-Kornek, and C. Kurts. 2006. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 176: 6770-6776.
11. Burgdorf, S., C. Scholz, A. Kautz, R. Tampe, and C. Kurts. 2008. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat. Immunol. 9: 558-566.
12. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
13. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. 4: 336-347. (Pubitemid 38649276)
14. Bardot, O., T. C. Aldridge, N. Latruffe, and S. Green. 1993. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192: 37-45.
15. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
16. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-82.
17. Yang, X. Y., L. H. Wang, T. Chen, D. R. Hodge, J. H. Resau, L. DaSilva, and W. L. Farrar. 2000. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists: PPARγ co-association with transcription factor NFAT. J. Biol. Chem. 275: 4541-4544.
18. phox and attenuates the respiratory burst. J. Immunol. 169: 2619-2626.
19. Cunard, R., Y. Eto, J. T. Muljadi, C. K. Glass, C. J. Kelly, and M. Ricote. 2004. Repression of IFN-γ expression by peroxisome proliferator-activated receptor γ. J. Immunol. 172: 7530-7536. (Pubitemid 38747616)
20. Sakamoto, J., H. Kimura, S. Moriyama, H. Odaka, Y. Momose, Y. Sugiyama, and H. Sawada. 2000. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem. Biophys. Res. Commun. 278: 704-711.
21. Racke, M. K., A. R. Gocke, M. Muir, A. Diab, P. D. Drew, and A. E. Lovett-Racke. 2006. Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis. J. Nutr. 136: 700-703.
22. Nencioni, A., F. Grunebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart. 2002. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor γ. J. Immunol. 169: 1228-1235.
23. + T cell anergy. J. Immunol. 178: 2122-2131.
24. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
25. + T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66: 1114-1122.
26. Karttunen, J., S. Sanderson, and N. Shastri. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89: 6020-6024.
27. + T cell tolerance. Eur. J. Immunol. 36: 2960-2970.
28. Coste, A., M. Dubourdeau, M. D. Linas, S. Cassaing, J. C. Lepert, P. Balard, S. Chalmeton, J. Bernad, C. Orfila, J. P. Seguela, and B. Pipy. 2003. PPARγ promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 19: 329-339.
29. He, W., Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, M. Nelson, E. Ong, J. M. Olefsky, and R. M. Evans. 2003. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100: 15712-15717.
30. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
31. Houde, M., S. Bertholet, E. Gagnon, S. Brunet, G. Goyette, A. Laplante, M. F. Princiotta, P. Thibault, D. Sacks, and M. Desjardins. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425: 402-406.
32. Castellino, F., P. E. Boucher, K. Eichelberg, M. Mayhew, J. E. Rothman, A. N. Houghton, and R. N. Germain. 2000. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191: 1957-1964.
33. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6: 369-376. (Pubitemid 24087229)
34. Zeelenberg, I. S., M. Ostrowski, S. Krumeich, A. Bobrie, C. Jancic, A. Boissonnas, A. Delcayre, J. B. Le Pecq, B. Combadiere, S. Amigorena, and C. Thery. 2008. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res. 68: 1228-1235.
35. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
36. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, H. Auchincloss, Jr., and M. H. Sayegh. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
37. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696.
38. Ohmori, Y., and T. A. Hamilton. 1998. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J. Biol. Chem. 273: 29202-29209.
39. Wei, R., and G. M. Jonakait. 1999. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-β1 (TGF-β1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 95: 8-18.
40. Zhao, W., W. Xie, Q. Xiao, D. R. Beers, and S. H. Appel. 2006. Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J. Neurochem. 99: 1176-1187.
41. Lin, S. X., W. G. Mallet, A. Y. Huang, and F. R. Maxfield. 2004. Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes. Mol. Biol. Cell 15: 721-733.
42. Mullbacher, A., and K. Flynn. 1996. Aspects of cytotoxic T cell memory. Immunol. Rev. 150: 113-127.
43. Flynn, K., and A. Müllbacher. 1996. Memory alloreactive cytotoxic T cells do not require costimulation for activation in vitro. Immunol. Cell Biol. 74: 413-420. (Pubitemid 26342126)